Jayanta Dey

Background

About Jayanta Dey

As a pharmaceutical physician, Jayanta has extensive experience in medical affairs communication, with a particular focus on drug placement strategies and digital innovations. He has led prelaunch and launch activities for numerous innovator and generic molecules across geographies over the last seven years, predominantly in oncology portfolios. In his current role, Jayanta is responsible for the DLL3/ CD3 TcE portfolio at Boehringer Ingelheim globally. Prior to joining the pharmaceutical industry, he worked for three years in a clinical setting managing patients in both corporate and resource-limited environments. With a strong clinical research background from the Christian Medical College Vellore, India, he aspires to translate advances in medical science that address high unmet medical needs and, in turn, influence patient lives.